Innovative microfluidic chip uses only standard lab microscope to spot nano-biomolecules without any fluorescent labels
A novel invention by a team of researchers from the National University of Singapore (NUS) holds promise for a faster and cheaper way to diagnose diseases with high accuracy. Professor Zhang Yong from the Department of Biomedical Engineering at the NUS Faculty of Engineering and his team have developed a tiny microfluidic chip that could effectively detect minute amounts of biomolecules without the need for complex lab equipment.
Diseases diagnostics involves detection and quantification of nano-sized bio-particles such as DNA, proteins, viruses, and exosomes (extracellular vesicles). Typically, detection of biomolecules such as proteins are performed using colorimetric assays or fluorescent labelling with a secondary antibody for detection, and requires complex optical detection equipment such as fluorescent microscopy or spectrophotometry.
One alternative to reduce cost and complexity of disease detection is the adoption of label-free techniques, which are gaining traction in recent times. However, this approach requires precision engineering of nano-features (in a detection chip), complex optical setups, novel nano-probes (such as graphene oxide, carbon nanotubes, and gold nanorods) or additional amplification steps such as aggregation of nanoparticles to achieve sensitive detection of biomarkers.
“Our invention is an example of disruptive diagnostics. This tiny biochip can sensitively detect proteins and nano-sized polymer vesicles with a concentration as low as 10ng/mL (150 pM) and 3.75?g/mL respectively. It also has a very small footprint, weighing only 500 mg and is 6mm³ in size. Detection can be performed using standard laboratory microscopes, making this approach highly attractive for use in point-of-care diagnostics,” explained Prof Zhang.
His team, comprising Dr Kerwin Kwek Zeming and two NUS PhD students Mr Thoriq Salafi and Ms Swati Shikha, published their findings in scientific journal Nature Communications on 28 March 2018.
Novel approach for disease diagnosis
This novel fluorescent label-free approach uses the lateral shifts in the position of the microbead substrate in pillar arrays, for quantifying the biomolecules, based on the change in surface forces and size, without the need of any external equipment. Due to the usage of lateral displacement, the nano-biomolecules can be detected in real-time and the detection is significantly faster in comparison to fluorescent label based detection.
“These techniques can also be extended to many other types of nano-biomolecules, including nucleic acid and virus detection. To complement this chip technology, we are also developing a portable smartphone-based accessory and microfluidic pump to make the whole detection platform portable for outside laboratory disease diagnostics. We hope to further develop this technology for commercialisation,” said Prof Zhang.
The Latest on: Disease detection
via Google News
The Latest on: Disease detection
- New markers for early detection of heart disease, diabeteson August 16, 2019 at 12:29 pm
A new guideline from the Endocrine Society recommends measuring five additional markers of metabolic risk — waistline, blood pressure, HDL cholesterol, blood fats, and blood sugar — for early ...
- Novel Technologies Driving Infectious Disease Management in 2019: Includes Growth Opportunities & Companies to Action - ResearchAndMarkets.comon August 15, 2019 at 9:21 am
Lyme Disease, and Urinary Tract Infections (UTIs). Molecular Diagnostics: Polymerase chain reaction (PCR) has been proved to be the most accurate diagnostic test for genomic biomarker detection ...
- Chronic Obstructive Pulmonary Disease and Arthritis Among US Adults, 2016on August 15, 2019 at 7:14 am
Health care providers may assess COPD and arthritis symptoms for earlier detection of each condition and recommend ... and self-management education programs such as the Chronic Disease ...
- Infectious Disease Diagnostics Market to Surpass US$ 25.7 Billion Threshold by 2026 Globally | Latest Insights on Trends and Challengeson August 13, 2019 at 7:05 am
Cepheid received the U.S. Food & Drug Administration clearance to market Xpert Xpress Strep A test in October 2017, which provides rapid, accurate, and reliable molecular detection of Streptococcus ...
- Johne’s Disease and Detection in Beef Cattle – Part I, Frequently Asked Questionson August 12, 2019 at 1:02 am
What is Johne’s Disease? Johne’s (pronounced Yo-knees) Disease is a chronic disease of profuse, watery diarrhea and weight loss or “wasting” in adult cattle (Figure 1) caused by the bacterium ...
- NHS investing £250M in new AI lab to target earlier cancer detection, dementiaon August 9, 2019 at 10:57 am
AI tools also could help identify patients most at risk of diseases such as heart disease or dementia ... in harnessing new technology to treat and prevent, from earlier cancer detection to spotting ...
- Endoscope Leak Detection Device Market to Witness Heightened Revenue Growth in the Next Decadeon August 9, 2019 at 9:36 am
According to Society of Gastroenterology Nurses and Associates (SGNA) & Centers for Disease Control and Prevention (CDC fact sheet), endoscope leak detection devices are probably not going to be ...
- LumiGrow Partners With Sensor Supplier on Early Disease Detection Technologyon August 8, 2019 at 2:35 pm
Lighting company LumiGrow has launched a new product line of early disease detection sensors and services, made possible through a new partnership. “Our partnership with Scanit Technologies marks a ...
- NaturalShrimp facilities placed under quarantine due to viral disease detectionon August 8, 2019 at 10:21 am
NaturalShrimp Incorporated has infored that it received a quarantine notice on August 5 from the Texas Parks and Wildlife Department for the company’s facility in La Coste, Texas, due to the detection ...
via Bing News